Previous Article | Next Article ![]()
Infect. Immun., 06 1997, 2060-2066, Vol 65, No. 6
M Wuorela, S Jalkanen, J Kirveskari, P Laitio and K Granfors
The expression of serologic HLA-B27 epitopes on leukocytes of patients with
reactive arthritis or ankylosing spondylitis has been shown to be modified
in the course of the disease. The purpose of this work was to study whether
phagocytosis of arthritis-triggering microbes in vitro alters the
expression of HLA-B27 molecules on human antigen-presenting cells and to
characterize the underlying mechanisms. Human monocytes and HLA-B27- or
HLA-A2-transfected human U-937 cells were exposed to Yersinia
enterocolitica serotype O:3. The expression of different epitopes of
HLA-B27 was monitored by using immunofluorescence, and their synthesis was
determined by quantitative immunoprecipitation. Our results show that
phagocytosis of Y. enterocolitica serotype O:3 changed the expression of
serological HLA-B27 epitopes. This was due to the reduced synthesis of
HLA-B27 molecules. The expression of especially the epitopes which depend
on the presence of peptides in the antigen-binding groove was changed. The
expression of the ME1 epitope, which has been shown to be important for
T-cell recognition in patients with reactive arthritis, was decreased.
Down-regulation of epitopes important for the T-cell recognition may impair
the elimination of arthritis-triggering microbes and lead to persistent
infection. In addition, Y. enterocolitica serotype O:3 seemed to alter the
repertoire of peptides presented by the HLA-B27 molecules on human
monocytes. This may have a role in the pathogenesis of reactive arthritis
via an autoimmune mechanism.
Copyright © 1997, American Society for Microbiology
Yersinia enterocolitica serotype O:3 alters the expression of serologic HLA-B27 epitopes on human monocytes
Department in Turku, National Public Health Institute, University of Turku, Finland. maarit.wuorela@utu.fi
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|